ACETYLON PHARMACEUTICALS; INC.;ACETYLON PHARMACEUTICALS, INC.;TAMANG, DAVID, LEE
发明人:
JONES, SIMON, S.,MIN, CHENGYIN,TAMANG, DAVID, LEE,YANG, MIN
申请号：
SG11201700094T
公开号：
SG11201700094TA
申请日:
2015.07.06
申请国别(地区):
SG
年份:
2017
代理人:
摘要：
Provided herein are combinations comprising an HDAC inhibitor and azacitidine for the treatment of leukemia in a subject in need thereof. Provided herein are combinations comprising an HDAC inhibitor and azacitidine for the treatment of acute myelogenous leukemia in a subject in need thereof. Also provided herein are methods for treating leukemia in a subject in need thereof, comprising administering to the subject an effective amount of the above combination or an HDAC inhibitor, as well as methods for treating acute myelogenous leukemia in a subject in need thereof, comprising administering to the subject an effective amount of the above combination or an HDAC inhibitor.
